ITRM
NASDAQ · Pharmaceuticals
Iterum Therapeutics Plc
$0.04
+0.01 (+18.86%)
Open$0.04
Previous Close$0.04
Day High$0.04
Day Low$0.03
52W High$1.28
52W Low—
Volume—
Avg Volume39.5K
Market Cap746.1K
P/E Ratio—
EPS$-0.75
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.84M | 2.52M | 2.36M |
| Net Income | 737.1K | 595.8K | 463.7K |
| Profit Margin | 25.9% | 23.7% | 19.6% |
| EBITDA | 1.27M | 1.08M | 1.08M |
| Free Cash Flow | 617.3K | 603.4K | 596.2K |
| Rev Growth | +5.6% | +6.9% | +16.3% |
| Debt/Equity | 0.35 | 0.29 | 0.29 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |